Also known as follow-on biologics, biosimilars are not like generic pharmaceuticals which can be analyzed in a laboratory to confirm that they are exact copies of chemical drugs...

Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.

Rockland Immunochemicals has produced a new Anti-NF-κB monoclonal antibody validated by several assays relevant for discovery including immunofluorescence microscopy, immunohistochemistry, western blotting and ELISA.

AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 ...

MedImmune today announced an in-licensing agreement with Amgen for a novel monoclonal antibody targeting the IL-1 pathway. The antibody, AMG 108, a fully human monoclonal antibody to the IL-1 receptor, has been studied in multiple phase 1 and phase 2 clinical trials and will now be explored by MedImmune ...

Argos Therapeutics announced that it has initiated dosing of patients in a Phase 1 clinical trial of its monoclonal antibody-based therapy, AGS-009, for the treatment of systemic lupus erythematosus (SLE). AGS-009 is a humanized immunoglobulin G4 (IgG4) monoclonal antibody (mAb) with the ability to bind and neutralize human interferon alpha ...

Neogenix Oncology, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued patent number 7,829,678 B2, with claims relating to 16C3 antibody, the company's monoclonal antibody for colorectal and pancreatic cancer.

Progenics Pharmaceuticals, Inc. today announced the award of a grant totaling $4,143,652 from the National Institutes of Health (NIH) for Progenics' program to develop novel monoclonal antibodies to treat Clostridium difficile (C. difficile) infection.

NEW YORK, Oct. 4 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Anti-CD20 Monoclonal Antibodies Industry http://www.reportlinker.com/p0305155/Global-Anti-CD20-Monoclonal-Antibodies-Industry.html This report analyzes the Global market for Anti-CD20 Monoclonal Antibodies in US$ Million. Annual estimates ...

LIEGE, Belgium, Sept. 22 /- Diagenode announced today that it has released two additional 5-hmC antibodies to complement its original 5-hmC (rat) monoclonal antibody. The two new 5-hmC monoclonal antibody (mouse) and polyclonal antibody (rabbit) antibodies give researchers additional choices for enriching and analyzing 5-hmC in their methylation studies. ...

BOSTON, Sept. 22 /- PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL ) and leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released two new white papers from leading biosimilar experts that provide key insights into emerging areas of biosimilar development. ...

NEW YORK, Sept. 21 /- Reportlinker.com announces that a new market research report is available in its catalogue: IP Overview – "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010 http://www.reportlinker.com/p0296354/IP-Overview-–-"Monoclonal-Antibodies-against-digestive-system-cancers"-Patent-Landscape-2010.html In order to fight...